Londian Wason Signs Cooperation Agreement in Kazakhstan to Jointly Build a High-Performance Electrolytic Copper Foil Production Base with NAIKAN Ltd. 
From Robot Companions to Robot Cafe: Star Plus Legend Reimagines Consumer Experiences Through IP+Physical AI 
Hong Kong International Wine & Spirits Fair attracts over 8,200 buyers with enthusiastic participation on Public Day 
Six dirhams a gate. The real 2026 cost of a Dubai commute and three ways out 
Spiking Joins IBM Z Day 2026 Asia Pacific Special Edition Track as a Friend of the IBM Z Community FDA accepts supplemental Biologics License Application for Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma
First new treatment regimen in more than 20 years to significantly improve outcomes in people…
Towards Next-Generation Digital Therapeutics – BELL Therapeutics Announces New Partnership with Prof. Jung, Seoul National University Hospital
BELL’s new partnership will shed light on further potentials for digital therapeutics by overcoming limitations…
Eloboss Introduces Gaming Solution by Connecting Players with Experts to Improve League Rating
Eloboss, a gaming solution provides a wide range of services to help players improve CS:GO…
Bintai Kinden Appointed by South Korean Company to Market Piping and Fitting Products
PETALING JAYA, Malaysia, Aug 16, 2022 – (ACN Newswire) – Mechanical and electrical (M&E) engineering…
Axo Announces Acquisition of Defero, a Leading Digital Credit-Scoring and Financial Management Platform
Addition of Defero’s Consumer-Focused Credit Scoring Platform Further Differentiates Axo as the Broker-of-Choice in the…
Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics
Zarrinpar Laboratory finds that engineering of native bacteria for therapeutic applications facilitates long term engraftment…
TELA Bio Announces Pricing of Public Offering of Common Stock
MALVERN, Pa., Aug. 15, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…
Mydecine Reports Financial Results for the Second Quarter of Fiscal Year 2022
DENVER, Aug. 15, 2022 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE:…
Fulcrum Therapeutics Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage…
Zijin Mining Announces 2022 Interim Results: Achieved 89.95% Increase in Net Profit Attributable to Owners
HONG KONG, Aug 16, 2022 – (ACN Newswire) – Zijin Mining Group Co., Ltd. (2899.HK;…
Essex Bio-Technology Included in “Forbes Asia’s Best Under A Billion 2022”
HONG KONG, Aug 16, 2022 – (ACN Newswire) – Essex Bio-Technology Ltd (“EssexBio” or the…
Total Economic Impact Study Reveals Ivanti Neurons for Unified Endpoint Management Solutions Delivered 261% ROI
New study finds Ivanti Neurons for UEM platform delivered benefits of $2.24 million over three…
Healthy Extracts Reports Record Second Quarter 2022, Net Revenue up 93% with Strong Subscription-Based Revenue Growth
LAS VEGAS, Aug. 15, 2022 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator…
vTv Therapeutics Announces 2022 Second Quarter Financial Results and Provides Corporate Update
Paul Sekhri appointed as President, Chief Executive Officer and Board member. Entered into agreements with…
Deveron Announces Dates for Q2 2022 Earnings Release
Toronto, Ontario–(Newsfile Corp. – August 15, 2022) – Deveron Corp. (TSXV: FARM) (“Deveron” or the…
Plurilock Closes First Tranche of Non-Brokered Private Placement of Convertible Debenture Units
Vancouver, British Columbia–(Newsfile Corp. – August 15, 2022) – Plurilock Security Inc. (TSXV: PLUR) (OTCQB:…
Siebert Reports Second Quarter 2022 Financial Results
NEW YORK–(BUSINESS WIRE)–Siebert Financial Corp. (NASDAQ: SIEB) (“Siebert”), a mission-driven provider of financial services, today…
Resverlogix Announces Appointment of New Chief Scientific Officer
CALGARY, Alberta, Aug. 15, 2022 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”) (TSX:RVX) today announced the…
ABVC BioPharma Reports Second Quarter 2022 Financial and Operational Results
FREMONT, CA, Aug. 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (Nasdaq:…
Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2022 and Recent Corporate Progress
SAN DIEGO, Aug. 15, 2022 (GLOBE NEWSWIRE) — Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company”…